NCT03234985View on ClinicalTrials.gov

Study of Intracellular Nucleotide Pools Determination as Biomarker of the Efficacy of the Induction Treatment in Acute Myeloid Leukemia

CompletedOBSERVATIONAL
Enrollment

83

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

October 25, 2021

Study Completion Date

October 25, 2021

Conditions
Acute Myeloid Leukemia
Interventions
BIOLOGICAL

Biological analyses

Biological analyses will be realized on samples collected before induction treatment and at the end of bone marrow aplasia i.e. about day 30 to determine the nucleotide pools in peripheral blood mononuclear cells.

Trial Locations (1)

69495

Service d'hématologie - Centre Hospitalier Lyon Sud - Hospices Civils de LYON, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03234985 - Study of Intracellular Nucleotide Pools Determination as Biomarker of the Efficacy of the Induction Treatment in Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter